• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种调节中国仓鼠卵巢细胞突变体中药物通透性的表面糖蛋白。

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

作者信息

Juliano R L, Ling V

出版信息

Biochim Biophys Acta. 1976 Nov 11;455(1):152-62. doi: 10.1016/0005-2736(76)90160-7.

DOI:10.1016/0005-2736(76)90160-7
PMID:990323
Abstract

Chinese hamster ovary cells selected for resistance to colchicine display pleiotropic cross-resistance to a wide range of amphiphilic drugs. The drug-resistant phenotype is due to a membrane alteration which reduces the rate of drug permeation. Surface labelling studies reveal that drug-resistant Chinese hamster ovary cell membranes possess a carbohydrate-containing component of 170 000 daltons apparent molecular weight which is not observed in wild type cells. Through studies of the metabolic incorporation of carbohydrate and protein precursors, and through the use of selective proteolysis, this component is shown to be a cell surface glycoprotein. Since this glycoprotein appears unique to mutant cells displaying altered drug permeability, we have designated it the P glycoprotein. The relative amount of surface labelled P glycoprotein correlates with the degree of drug resistance in a number of independent mutant and revertant clones. A similar high molecular weight glycoprotein is also present in drug-resistant mutants from another hamster cell line. Observations on the molecular basis of pleiotropic drug resistance are interpreted in terms of a model wherein certain surface glycoproteins control drug permeation by modulating the properties of hydrophobic membrane regions...

摘要

经筛选获得秋水仙碱抗性的中国仓鼠卵巢细胞对多种两亲性药物表现出多效性交叉抗性。这种耐药表型是由于细胞膜改变导致药物渗透速率降低所致。表面标记研究表明,耐药的中国仓鼠卵巢细胞膜具有一种表观分子量为170000道尔顿的含碳水化合物成分,而野生型细胞中未观察到这种成分。通过对碳水化合物和蛋白质前体的代谢掺入研究,以及通过使用选择性蛋白酶解,表明该成分是一种细胞表面糖蛋白。由于这种糖蛋白似乎是显示药物通透性改变的突变细胞所特有的,我们将其命名为P糖蛋白。在许多独立的突变体和回复体克隆中,表面标记的P糖蛋白的相对量与耐药程度相关。另一种仓鼠细胞系的耐药突变体中也存在类似的高分子量糖蛋白。关于多效性耐药分子基础的观察结果,根据一种模型进行了解释,在该模型中,某些表面糖蛋白通过调节疏水膜区域的特性来控制药物渗透……

相似文献

1
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.一种调节中国仓鼠卵巢细胞突变体中药物通透性的表面糖蛋白。
Biochim Biophys Acta. 1976 Nov 11;455(1):152-62. doi: 10.1016/0005-2736(76)90160-7.
2
Drug resistance and membrane alteration in mutants of mammalian cells.
Can J Genet Cytol. 1975 Dec;17(4):503-15. doi: 10.1139/g75-064.
3
Multidrug-resistance phenotype in Chinese hamster ovary cells.中国仓鼠卵巢细胞中的多药耐药表型。
Cancer Treat Rep. 1983 Oct;67(10):869-74.
4
Altered drug permeability in mammalian cell mutants.
Adv Exp Med Biol. 1977;84:247-64. doi: 10.1007/978-1-4684-3279-4_12.
5
Modulation of drug permeability in Chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteins.
Biochim Biophys Acta. 1977 Jun 2;467(2):238-50. doi: 10.1016/0005-2736(77)90199-7.
6
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.从秋水仙碱通透性降低的中国仓鼠卵巢细胞突变体的质膜囊泡中纯化P-糖蛋白。
J Biol Chem. 1979 Dec 25;254(24):12701-5.
7
Characteristics of concanavalin A-resistant Chinese hamster ovary cells and certain revertants.刀豆球蛋白A抗性中国仓鼠卵巢细胞及某些回复突变体的特征
J Cell Physiol. 1979 Jul;100(1):39-54. doi: 10.1002/jcp.1041000105.
8
Colchicine permeation is required for inhibition of concanavalin A capping in Chinese hamster ovary cells.抑制中国仓鼠卵巢细胞中伴刀豆球蛋白A帽化需要秋水仙碱渗透。
Proc Natl Acad Sci U S A. 1975 Nov;72(11):4516-20. doi: 10.1073/pnas.72.11.4516.
9
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.表达多药耐药性和细胞表面P-糖蛋白的柔红霉素耐药中国仓鼠卵巢细胞
Cancer Res. 1983 Sep;43(9):4413-9.
10
Drug-resistant mutants of Chinese hamster ovary cells possess an altered cell surface carbohydrate component.
J Supramol Struct. 1976;4(4):521-6. doi: 10.1002/jss.400040412.

引用本文的文献

1
Association Between ABCB1 Gene Polymorphism with Hyperglycemia and MACE in Patients Undergoing Clopidogrel Treatment After PCI.经皮冠状动脉介入治疗后接受氯吡格雷治疗患者中ABCB1基因多态性与高血糖及主要不良心血管事件的关联
Pharmgenomics Pers Med. 2025 Aug 25;18:209-217. doi: 10.2147/PGPM.S529276. eCollection 2025.
2
rs2231142 (421 C>A, Q141K) Is More Functionally Influential than rs2231137 (34 G>A, V12M) on Anticancer Drug Resistance Mediated by the Haplotype In Vitro.rs2231142(421 C>A,Q141K)在体外对由单倍型介导的抗癌药物耐药性的功能影响比rs2231137(34 G>A,V12M)更大。
Int J Mol Sci. 2025 Aug 1;26(15):7428. doi: 10.3390/ijms26157428.
3
A Quantitative Model of Chemotherapeutic Drug Sensitivity as a Function of P-Glycoprotein Expression.
作为P-糖蛋白表达函数的化疗药物敏感性定量模型。
Molecules. 2025 Jul 18;30(14):3014. doi: 10.3390/molecules30143014.
4
Understanding and overcoming multidrug resistance in cancer.了解并克服癌症中的多药耐药性。
Nat Rev Clin Oncol. 2025 Jul 29. doi: 10.1038/s41571-025-01059-1.
5
Chemosensory role of intracellular TAS2Rs, the activation of which triggers drug excretion by ABCB1 in cancer cells.细胞内味觉受体2型(TAS2Rs)的化学感应作用,其激活可触发癌细胞中ABCB1介导的药物排泄。
Sci Rep. 2025 Jul 28;15(1):27451. doi: 10.1038/s41598-025-12889-5.
6
A novel ligand-based convolutional neural network for identification of P-glycoprotein ligands in drug discovery.一种用于药物发现中识别P-糖蛋白配体的基于新型配体的卷积神经网络。
Mol Divers. 2025 Jul 25. doi: 10.1007/s11030-025-11301-8.
7
Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption.氨基葡萄糖激活肠道P-糖蛋白,抑制药物吸收。
Nat Commun. 2025 Jul 2;16(1):6100. doi: 10.1038/s41467-025-61437-2.
8
Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf.多重耐药性:我们还怕那只大坏狼吗?
Pharmaceuticals (Basel). 2025 Jun 14;18(6):895. doi: 10.3390/ph18060895.
9
A Systematic Review of ABCB1 Polymorphisms and Antiseizure Medication Resistance: Insights from Effect Size and Study Power Analysis.ABCB1基因多态性与抗癫痫药物耐药性的系统评价:效应量和研究效能分析的见解
Int J Mol Sci. 2025 Jun 10;26(12):5548. doi: 10.3390/ijms26125548.
10
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.